BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30624885)

  • 1. Bicyclic RGD Peptides with Exquisite Selectivity for the Integrin α
    Bernhagen D; Jungbluth V; Quilis NG; Dostalek J; White PB; Jalink K; Timmerman P
    ACS Comb Sci; 2019 Mar; 21(3):198-206. PubMed ID: 30624885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Affinity α
    Bernhagen D; Jungbluth V; Gisbert Quilis N; Dostalek J; White PB; Jalink K; Timmerman P
    ACS Comb Sci; 2019 Aug; 21(8):598-607. PubMed ID: 31269394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Affinity RGD-Knottin Peptide as a New Tool for Rapid Evaluation of the Binding Strength of Unlabeled RGD-Peptides to α
    Bernhagen D; De Laporte L; Timmerman P
    Anal Chem; 2017 Jun; 89(11):5991-5997. PubMed ID: 28492301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Grafting aminocyclopentane carboxylic acids onto the RGD tripeptide sequence generates low nanomolar alphaVbeta3/alphaVbeta5 integrin dual binders.
    Casiraghi G; Rassu G; Auzzas L; Burreddu P; Gaetani E; Battistini L; Zanardi F; Curti C; Nicastro G; Belvisi L; Motto I; Castorina M; Giannini G; Pisano C
    J Med Chem; 2005 Dec; 48(24):7675-87. PubMed ID: 16302808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bicyclic RGD peptides enhance nerve growth in synthetic PEG-based Anisogels.
    Vedaraman S; Bernhagen D; Haraszti T; Licht C; Castro Nava A; Omidinia Anarkoli A; Timmerman P; De Laporte L
    Biomater Sci; 2021 Jun; 9(12):4329-4342. PubMed ID: 33724266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bicyclic RGD peptides with high integrin α
    Cipriani F; Bernhagen D; García-Arévalo C; de Torre IG; Timmerman P; Rodríguez-Cabello JC
    Biomed Mater; 2019 Mar; 14(3):035009. PubMed ID: 30630151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered cystine-knot peptides that bind alpha(v)beta(3) integrin with antibody-like affinities.
    Silverman AP; Levin AM; Lahti JL; Cochran JR
    J Mol Biol; 2009 Jan; 385(4):1064-75. PubMed ID: 19038268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic RGD and
    Panzeri S; Arosio D; Gazzola S; Belvisi L; Civera M; Potenza D; Vasile F; Kemker I; Ertl T; Sewald N; Reiser O; Piarulli U
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33339382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-specific inhibition of integrin alpha v beta 3-vitronectin association by a ser-asp-val sequence through an Arg-Gly-Asp-binding site of the integrin.
    Choi Y; Kim E; Lee Y; Han MH; Kang IC
    Proteomics; 2010 Jan; 10(1):72-80. PubMed ID: 19882657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered cystine knot peptides that bind alphavbeta3, alphavbeta5, and alpha5beta1 integrins with low-nanomolar affinity.
    Kimura RH; Levin AM; Cochran FV; Cochran JR
    Proteins; 2009 Nov; 77(2):359-69. PubMed ID: 19452550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-Activity Relationship of RGD-Containing Cyclic Octapeptide and αvβ3 Integrin Allows for Rapid Identification of a New Peptide Antagonist.
    Silva A; Xiao W; Wang Y; Wang W; Chang HW; Ames JB; Lam KS; Zhang Y
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32349271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineered fibronectin type III domain with a RGDWXE sequence binds with enhanced affinity and specificity to human alphavbeta3 integrin.
    Richards J; Miller M; Abend J; Koide A; Koide S; Dewhurst S
    J Mol Biol; 2003 Mar; 326(5):1475-88. PubMed ID: 12595259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct structural requirements for binding of the integrins alphavbeta6, alphavbeta3, alphavbeta5, alpha5beta1 and alpha9beta1 to osteopontin.
    Yokosaki Y; Tanaka K; Higashikawa F; Yamashita K; Eboshida A
    Matrix Biol; 2005 Sep; 24(6):418-27. PubMed ID: 16005200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designed synthetic analogs of the α-helical peptide temporin-La with improved antitumor efficacies via charge modification and incorporation of the integrin αvβ3 homing domain.
    Diao Y; Han W; Zhao H; Zhu S; Liu X; Feng X; Gu J; Yao C; Liu S; Sun C; Pan F
    J Pept Sci; 2012 Jul; 18(7):476-86. PubMed ID: 22641352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new cyclic RGD peptide dimer for integrin αvβ3 imaging.
    Ma H; Hao P; Zhang L; Ma C; Yan P; Wang RF; Zhang CL
    Eur Rev Med Pharmacol Sci; 2016; 20(4):613-9. PubMed ID: 26957261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction Mechanism and Clustering among RGD Peptides and Integrins.
    Dong X; Yu Y; Wang Q; Xi Y; Liu Y
    Mol Inform; 2017 May; 36(5-6):. PubMed ID: 28004516
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.